Latest news & insights
Boyds bolsters Regulatory Affairs team with appointment of Claire Scruton
Boyds has announced a key appointment in support of its continuing growth plans, welcoming Claire Scruton as Senior Manager of CMC Regulatory Affairs. At Boyds,
American Society of Gene and Cell Therapy Annual Meeting, Washington
Professor Alan Boyd will be chairing the Audentes Symposium session at the American Society of Gene and Cell Therapy (ASGCT) annual meeting in Washington on
Boyds strengthens Regulatory team with appointment of Sabine Rühle
Boyds has announced a key appointment in support of its continued growth plans, welcoming Dr Sabine Rühle as Senior Associate of Regulatory Affairs. A member of
Boyds builds on growth plans with clinical operations hire
Boyds has further strengthened its clinical operations offering with the appointment of Pippa Bjaaland as a Senior Clinical Research Associate (CRA), as part of an
New Dublin office in Ireland for Boyds
Boyds has opened an office in Dublin, Ireland in a step that will ensure the continuity of service to its clients once the UK leaves
Professor Alan Boyd appointed as Non-Executive Director at Clinigen Group
Boyds’ CEO, Professor Alan Boyd, has been appointed as a Non-Executive Director at global pharmaceutical and services company, Clinigen Group. Clinigen’s unique combination of businesses
Boyds presented with Queen’s Award for Enterprise
Boyds has been presented with one of the UK’s most prestigious business awards – The Queen’s Award for Enterprise, International Trade for Outstanding Short-Term Growth
Boyds to chair and present at TOPRA Symposium
This year’s TOPRA Symposium will take place this October in Stockholm and is held in partnership with the Swedish MPA. The three-day symposium will cover
